Article
28 Oct 2022
Life Sciences Innovation A True Bellwether Of The Sector's Strength
AUTHORS CONTENT
Article
02 Sep 2022
Cross-Border Funding For Life Science Companies
Article
17 Aug 2022
Did The CRA Shred Its Old SR&ED Policy On Eligibility Of Work?
Article
18 May 2022
Canadian Life Sciences: VC Investment Report Q1 2022
Article
01 Mar 2022
Canadian Life Sciences: A Look Back At 2021
Article
03 Dec 2021
Accelerated Growth In Canada's Life Sciences Industry
Article
03 Dec 2021
Life Sciences And Real Estate: New Opportunities
Article
16 Nov 2021
Chapter 1: Emerging Companies In Canada: Data And Digital Technology And Life Sciences
Article
28 Aug 2021
Canada's New Biomanufacturing And Life Sciences Investment Strategy
Article
21 Apr 2021
Canadian Companies And SPACs: Special Considerations
Article
10 Dec 2020
Financing Life Sciences On Both Sides Of The Border (Video)
Article
07 Dec 2020
SEC Broadens Accredited Investor Definition To Allow For Expanded Participation In U.S. Private Offering
Article
26 Nov 2020
Proposed OBCA Changes To Open Province For Cross-border Businesses And Foreign Investors
Article
06 Jun 2020
Torys Business Brief: A Turning Point For Canada's Life Sciences
Article
05 Jun 2020
Cracking Down On COVID-19 Fraud: U.S. And Canadian Securities Regulatory Enforcement Update
Article
28 May 2020
Pandemic's Mandate To Innovate A Turning Point For Life Sciences
Article
20 May 2020
New COVID-19 Government Support For Life Sciences Companies
Article
12 Nov 2019
The State Of Play In North American Cannabis Investment
Article
03 Jan 2019
2018 Farm Bill Signed Into Law, Legalizing Cultivation And Production Of Hemp In The U.S
Article
16 Oct 2018
New IRS Approach To U.S. Tax-Deferred Spin-Offs A Boon To Pharma And Tech
